Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Claudio Piersimoni

Showing results (1-10 of 26) with videos related to

Pageof 3
Sort By:
Journal of Clinical Microbiology|December 10, 2003
Relevance of commercial amplification methods for direct detection of Mycobacterium tuberculosis complex in clinical samplesClaudio Piersimoni, Claudio Scarparo
The Lancet. Infectious Diseases|May 13, 2008
Pulmonary infections associated with non-tuberculous mycobacteria in immunocompetent patientsClaudio Piersimoni, Claudio Scarparo
Emerging Infectious Diseases|October 1, 2009
Extrapulmonary infections associated with nontuberculous mycobacteria in immunocompetent personsClaudio Piersimoni, Claudio Scarparo
Journal of Clinical Microbiology|January 5, 2006
Current perspectives on drug susceptibility testing of Mycobacterium tuberculosis complex: the automated nonradiometric systemsClaudio Piersimoni, Armando Olivieri, Luca Benacchio, et al.
Journal of Clinical Microbiology|November 21, 2008
Impact of a chemistry-based DNA extraction method on performance of a commercial amplification assay for detection of Mycobacterium tuberculosis complexClaudio Piersimoni, Giancarlo Gherardi, Domenico Nista, et al.
Journal of Clinical Tuberculosis and Other Mycobacterial Diseases|November 14, 2019
Comparative evaluation of Xpert MTB/RIF and the new Xpert MTB/RIF ultra with respiratory and extra-pulmonary specimens for tuberculosis case detection in a low incidence settingClaudio Piersimoni, Giancarlo Gherardi, Natascia Gracciotti, et al.
Journal of Clinical Microbiology|January 16, 2009
Unreliable detection of Mycobacterium xenopi by the nonradiometric Bactec MGIT 960 culture systemClaudio Piersimoni, Domenico Nista, Stefano Bornigia, et al.
Emerging Infectious Diseases|March 20, 2003
Mycobacterium celatum pulmonary infection in the immunocompetent: case report and reviewClaudio Piersimoni, Pier Giorgio Zitti, Domenico Nista, et al.
Journal of Clinical Microbiology|September 15, 2017
Improved Bactec MGIT 960 Pyrazinamide Test Decreases Detection of False Mycobacterium tuberculosis Pyrazinamide ResistanceAlessandro Mustazzolu, Angelo Iacobino, Federico Giannoni, et al.
Diagnostic Microbiology and Infectious Disease|November 30, 2002
Evaluation of the BACTEC MGIT 960 in comparison with BACTEC 460 TB for detection and recovery of mycobacteria from clinical specimensClaudio Scarparo, Paola Piccoli, Alessandra Rigon, et al.
Pageof 3

Showing results (1-10 of 26) with videos related to

Sort By:
Pageof 3
Journal of Clinical Microbiology|December 10, 2003
Relevance of commercial amplification methods for direct detection of Mycobacterium tuberculosis complex in clinical samplesClaudio Piersimoni, Claudio Scarparo
The Lancet. Infectious Diseases|May 13, 2008
Pulmonary infections associated with non-tuberculous mycobacteria in immunocompetent patientsClaudio Piersimoni, Claudio Scarparo
Emerging Infectious Diseases|October 1, 2009
Extrapulmonary infections associated with nontuberculous mycobacteria in immunocompetent personsClaudio Piersimoni, Claudio Scarparo
Journal of Clinical Microbiology|January 5, 2006
Current perspectives on drug susceptibility testing of Mycobacterium tuberculosis complex: the automated nonradiometric systemsClaudio Piersimoni, Armando Olivieri, Luca Benacchio, et al.
Journal of Clinical Microbiology|November 21, 2008
Impact of a chemistry-based DNA extraction method on performance of a commercial amplification assay for detection of Mycobacterium tuberculosis complexClaudio Piersimoni, Giancarlo Gherardi, Domenico Nista, et al.
Journal of Clinical Tuberculosis and Other Mycobacterial Diseases|November 14, 2019
Comparative evaluation of Xpert MTB/RIF and the new Xpert MTB/RIF ultra with respiratory and extra-pulmonary specimens for tuberculosis case detection in a low incidence settingClaudio Piersimoni, Giancarlo Gherardi, Natascia Gracciotti, et al.
Journal of Clinical Microbiology|January 16, 2009
Unreliable detection of Mycobacterium xenopi by the nonradiometric Bactec MGIT 960 culture systemClaudio Piersimoni, Domenico Nista, Stefano Bornigia, et al.
Emerging Infectious Diseases|March 20, 2003
Mycobacterium celatum pulmonary infection in the immunocompetent: case report and reviewClaudio Piersimoni, Pier Giorgio Zitti, Domenico Nista, et al.
Journal of Clinical Microbiology|September 15, 2017
Improved Bactec MGIT 960 Pyrazinamide Test Decreases Detection of False Mycobacterium tuberculosis Pyrazinamide ResistanceAlessandro Mustazzolu, Angelo Iacobino, Federico Giannoni, et al.
Diagnostic Microbiology and Infectious Disease|November 30, 2002
Evaluation of the BACTEC MGIT 960 in comparison with BACTEC 460 TB for detection and recovery of mycobacteria from clinical specimensClaudio Scarparo, Paola Piccoli, Alessandra Rigon, et al.
Pageof 3